Marion Dorsch
2016
In 2016, Marion Dorsch earned a total compensation of $2.9M as Chief Scientific Officer at Blueprint Medicines.
Compensation breakdown
Bonus | $150,000 |
---|---|
Option Awards | $2,691,326 |
Salary | $40,962 |
Total | $2,882,288 |
Dorsch received $2.7M in option awards, accounting for 93% of the total pay in 2016.
Dorsch also received $150K in bonus and $41K in salary.
Rankings
In 2016, Marion Dorsch's compensation ranked 3,336th out of 14,075 executives tracked by ExecPay. In other words, Dorsch earned more than 76.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,336 out of 14,075 | 76th |
Division Manufacturing | 1,160 out of 5,489 | 79th |
Major group Chemicals And Allied Products | 348 out of 1,895 | 82nd |
Industry group Drugs | 251 out of 1,538 | 84th |
Industry Pharmaceutical Preparations | 196 out of 1,176 | 83rd |
Source: SEC filing on April 28, 2017.
Dorsch's colleagues
We found five more compensation records of executives who worked with Marion Dorsch at Blueprint Medicines in 2016.
2016
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2016
Tracey McCain
Blueprint Medicines
Chief Legal Officer
2016
Kate Haviland
Blueprint Medicines
Chief Business Officer
2016
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2016
Michael Landsittel
Blueprint Medicines